Clinical Trial

MINIject Global Long-Term Follow-up Study

Study acronym: STAR-GLOBAL
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study will assess the long-term (up to 5 years) safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-08-20; most recent amendment 2026-06-10.
Status change: Recruiting → Active, Not Recruiting 2026-06-10
Trial Details
NCT Number NCT04524416
Lead Sponsor iSTAR Medical
Conditions Open Angle Glaucoma, Ocular Hypertension
Enrollment 116 participants
Start Date 2020-08-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-11